Evidence map›Paper›PMID 34307988›Full record

ArticleKidney international reports2021

Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis.

Nina A van de Lest, Aimée E Bakker, Kyra L Dijkstra, Malu Zandbergen, Sharon A C Heemskerk, Ron Wolterbeek, Jan A Bruijn, Marion Scharpfenecker

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nina A van de LestDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Aimée E BakkerDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Kyra L DijkstraDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Malu ZandbergenDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Sharon A C HeemskerkDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Ron WolterbeekMedical Statistics, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands.
Jan A BruijnDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Marion ScharpfeneckerDepartment of Pathology, Leiden University Medical Center, Leiden, Netherlands.
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe podocyte is thought to be the mainly affected cell type in focal segmental glomerulosclerosis (FSGS). However, recent studies have also indicated a role for glomerular endothelial cells and podocyte-endothelial crosstalk in FSGS development. An experimental model for podocyte injury showed that increased endothelin-1 (ET-1) signaling between podocytes and endothelial cells induces endothelial oxidative stress and subsequent podocyte loss. In the current study, we investigated endothelial endothelin receptor A (ET

methodsWe selected 39 biopsy samples of patients with FSGS and 8 healthy control subjects, and stained them for ET

resultsThe mean percentage of glomeruli with ET

conclusionTaking together our findings, we show that ET

Indexed as

crosstalkendothelin receptor Afocal segmental glomerulosclerosisglomerular endothelial cellsoxidative stresspodocytes

Identifiers

PMID34307988
PMCPMC8258598
OpenAlexW3157591377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.